Skip to main content

The history behind CryspIQ

For two and a half decades or more, organisations have followed one of the two data warehousing principles of Inmon and Kimball for preparation of data. Both methods have intrinsic benefits but leave organisations with some challenges in accessing warehoused data. By taking the best of both data warehousing practices a new paradigm is possible however, one fundamental mindshift is required to bring the value of data closer to the surface for business self service, analytics and reporting. This mindshift is the breaking of the human paradigm of clustering data in a format that represents the data source as this is the area that restricts data from being used in a more abstracted way.

The CryspIQ Journey

Below you can see the timeline of the CryspIQ journey from the initial idea through to the release to market.

The idea - Data Preparation – The New Way.

Read morecryspiq

Prototype build commenced.

cryspiq

Prototype testing commenced

cryspiq

Intellectual Property (IP) patenting commenced

Read morepatent

Prototype testing completed

cryspiq

Singapore patent issued

Read morepatent

v1 - CryspIQ On-Premise build completed

cryspiq

Japan patent issued

Read morepatent

US patent issued

Read morepatent

Hong Kong patent issued

Read morepatent

Conversion of CryspIQ from on-premise version to SAAS version commenced

cryspiq

Australia patent issued

Read morepatent

JTSI Innovation Booster Grant (IBG) awarded to complete user interface enhancements.

Read moreJTSI

v2 - CryspIQ SAAS build completed

Read morecryspiq

The Crysp relationship with CryspIQ

Since 2016, the Crysp team has undertaken the design, prototyping, development and patenting of CryspIQ decomposition methodology and universal structure. CryspIQ is a SAAS product that prepares, connects, centralises and secures all your valuable data across your organisation. It was built to simplify your data collation processes and reduce the time spent preparing data for analytics and reporting. Patents for CryspIQ have been granted in the US, Australia, Japan, Singapore, Hong Kong and China and are pending in other countries around the world.